Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Factors of treatment response in major depressive disorder

Trial Profile

Factors of treatment response in major depressive disorder

Suspended
Phase of Trial: Phase IV

Latest Information Update: 03 Feb 2010

At a glance

  • Drugs Duloxetine; Escitalopram; Venlafaxine
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Sep 2008 Status changed from recruiting to suspended as reported by Clinicaltrials.gov.
    • 11 Aug 2008 Planned number of patients changed from 120 to 140 as reported by ClinicalTrials.gov.
    • 21 Apr 2008 The expected completion date for this trial is now 1 Jun 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top